| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 6e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |